19 December 2017 Optical coherence tomography in gastroenterology: a review and future outlook
Author Affiliations +
Abstract
Optical coherence tomography (OCT) is an imaging technique optically analogous to ultrasound that can generate depth-resolved images with micrometer-scale resolution. Advances in fiber optics and miniaturized actuation technologies allow OCT imaging of the human body and further expand OCT utilization in applications including but not limited to cardiology and gastroenterology. This review article provides an overview of current OCT development and its clinical utility in the gastrointestinal tract, including disease detection/differentiation and endoscopic therapy guidance, as well as a discussion of its future applications.
Tsai, Leggett, Trindade, Sethi, Swager, Joshi, Bergman, Mashimo, Nishioka, and Namati: Optical coherence tomography in gastroenterology: a review and future outlook

1.

Introduction to Endoscopic Optical Coherence Tomography

Although great strides have been made with traditional white-light endoscopy (WLE), including high-definition imaging sensors, magnified endoscopy, and most recently enhanced contrast techniques such as narrow band imaging, there still exists a challenge to obtain clinically relevant diagnostic information.1,2 Since the first publication on optical coherence tomography (OCT) in the early 1990s,3 development of endoscopic OCT4 techniques and applications has become a major field of research.56.7.8 Recent studies on endoscopic OCT have shown great potential to increase diagnostic accuracy and improve disease management due to its high resolution, volumetric, and subsurface imaging capability. In gastroenterology, research institutes and commercial entities have developed a variety of endoscopic OCT tools to investigate and address issues along the gastrointestinal (GI) tract including the esophagus, stomach, pancreatico-biliary tract, small intestine, and colon. These tools not only provide methods to better understand the pathophysiology of GI diseases but also contribute to the improvement of GI disease management.

1.1.

Optical Coherence Tomography and Fourier-Domain Optical Coherence Tomography

The working principle of OCT is based on an optical ranging technique known as low coherence interferometry.9,10 An OCT system can measure the time delay and the signal intensity of the light reflected back from a sample. As opposed to ultrasound where direct detection of this time delay is possible, in OCT the light travels at a speed beyond the capability of electronic detection, and hence an interferometer such as a Michelson interferometer is used. In traditional time-domain OCT (TD-OCT), one arm of the interferometer has a scanning reference path delay that is translated over the designed imaging depth.11 Each sweep in depth provides a depth profile or A-scan. The second arm of the interferometer typically contains a scanning system that scans the light beam over the sample to collect multiple depth profiles forming a two-dimensional (2-D) image or B-scan. In endoscopic OCT systems, this arm is usually a fiber-optic probe for imaging inside the body. The scanning system and probe determine the field of view, working distance, and the lateral resolution of the imaging system.

In the early 2000s, the introduction of Fourier-domain detection dramatically increased the imaging speed and detection sensitivity of OCT technology.1213.14 While TD-OCT directly measures the interference signal, Fourier-domain OCT measures the spectrum of the interference signal, and the OCT axial scan is obtained by applying a Fourier transform on the detected spectrum without the need for scanning the reference path delay. Fourier-domain OCT can be divided into two implementations, namely spectral-domain OCT (SD-OCT), which measures the spectrum of the interference signal with a spectrometer,15 and swept source OCT (SS-OCT), also known as optical frequency domain imaging (OFDI), which measures the spectrum of the interference signal with a wavelength-swept light source and a photodetector.16,17 Due to the availability of existing technology, SS-OCT is typically used for applications requiring fast imaging speed at wavelengths of 1.3 and 1  μm, while SD-OCT is used for applications requiring high axial resolution from broadband light sources with shorter operating wavelengths.18,19 Since the first introduction of Fourier-domain OCT in endoscopic systems in 2007,20,21 SS-OCT at 1.3-μm wavelength has become the predominant technology of choice for endoscopic OCT applications, primarily due to the improved depth penetration in tissue with a longer wavelength source, increased sensitivity of a dual-balanced detection scheme, and the utilization of fiber optics for optical communication.17,21 To date, advances in wavelength-SSs, data acquisition, and scanning probe technologies have enabled multimegahertz high-speed endoscopic OCT imaging.2223.24

1.2.

Optical Probes

As OCT technology continues to mature, imaging probes have become a major development area for endoscopic OCT applications, as they directly interact with patients and determine the optical (lateral resolution, focal depth) and mechanical (scanning speed, sampling density) parameters that are essential for image quality. Previous review publications in the field25,26 have provided a comprehensive overview and summary of different imaging probe designs and thus we will cover only the probe variants at a high level. There are two major probe configurations as shown in Fig. 1, namely side viewing and forward-viewing probes. Side-viewing probes [Fig. 1(a)] are the most common configuration and used in the majority of endoscopic OCT studies, especially when relatively large image coverage within luminal anatomies is required. Depending on the working distance and lateral resolution requirements of the application, a probe can be packaged in different forms, such as a small diameter flexible sheath,4 large diameter inflatable balloon,27 or rigid housing.28 The scanning mechanism of these probes can be either proximally driven by a motorized fiber optic rotary joint via a drive shaft/torque cable or directly driven by a distal miniaturized scanner, with an additional pullback/push-forward mechanism to achieve three-dimensional (3-D) imaging. The forward viewing probes [Fig. 1(b)], on the other hand, provide a small field of view but offer a more intuitive viewing scheme similar to magnified endoscopy or endomicroscopy. Scanners are typically located distally in the probes and provide 2-D scanning such as raster,29 spiral,30 and Lissajou31 patterns depending on the actuators used in the probe designs. Forward-viewing probes are typically used in applications that require high magnification and integration with other microscopy modalities.

Fig. 1

Endoscopic probe designs and operating principle for OCT imaging: (a) side-viewing configuration rotates the light with longitudinal pullback to generate a series of radial images for three-dimensional reconstructions; (b) forward-viewing configuration scans the light in two-dimensions to achieve volumetric OCT imaging.

JBO_22_12_121716_f001.png

2.

Unmet Needs in Gastroenterology and the Benefit of Using Optical Coherence Tomography

Adoption of an advanced imaging technology like endoscopic OCT relies on whether the technology can address issues that cannot be effectively resolved, in terms of both capability and cost, by the current standard of care. It is estimated that 310,440 new GI cancer cases resulting in 157,700 deaths will occur in the United States in 2017.32 The survival rate from GI cancers can be improved by 5- to 10-fold if diagnosed at an early stage.32 Current standard procedures to achieve early detection depend on a three-step process: (1) identify a population at risk, (2) perform an endoscopic evaluation to identify a premalignant lesion, and (3) perform tissue retrieval (biopsy or resection) for pathological confirmation. High-definition WLE with magnification and narrow-band imaging can generally identify superficial lesions in the GI tract but small or flat lesions are often subtle and may be missed due to limitations in resolution and light penetration.33,34 In addition, subsurface malignant or premalignant lesions may not be visible on WLE.

The amount of tissue to be sampled is determined by the size and distribution of the premalignant condition. Barrett’s esophagus (BE) is the established precursor to esophageal adenocarcinoma. This lesion can extend over several centimeters of the human esophagus and is classified based on its length and distribution. The risk of cancer in BE increases with the degree of dysplasia,35,36 as the progression of BE to adenocarcinoma is thought to be a stepwise progression from specialized intestinal metaplasia (SIM), low-grade dysplasia (LGD), and high-grade dysplasia (HGD) to intramucosal carcinoma (IMC). Established surveillance protocols for BE recommend targeted biopsies of areas with mucosal abnormalities followed by random four quadrant biopsies at set intervals.37 However, this approach is limited by sampling error as less than 5% of the total surface area38 is evaluated. In addition, while dysplasia can manifest with a heterogeneous distribution within a BE segment, suggesting the samples may not truly reflect the degree of dysplasia.39 Other possible premalignant lesions, such as indeterminate strictures of the biliary tree, are not as easily sampled.40 An advantage of endoscopic OCT is in providing widefield, subsurface, and near-microscopic imaging to guide targeted tissue retrieval, which may obviate the need to acquire nonsuspicious tissue and improve diagnostic yield.

Endoscopic OCT can also be used as an imaging modality for posttreatment surveillance. GI diseases that are confined to the mucosa can usually be treated with tissue removal techniques such as endoscopic mucosal resection (EMR)41,42 and endoscopic submucosal dissection,43 or ablative therapies, such as argon plasma coagulation,44 radiofrequency ablation (RFA),45 and cryotherapy.46,47 The goal of these methods is the same—to remove or destroy the abnormal tissue and allow normal tissue to grow back. Currently, the standard practice for assessment of treatment efficacy is continuous endoscopic surveillance at set intervals.48 In BE, for example, treated areas typically recover in the form of neosquamous epithelium, which is endoscopically similar to normal squamous epithelium. During treatment, Barrett’s glands may become buried under neosquamous epithelium and may elude detection by surveillance biopsies. Although the long-term clinical significance of buried BE is still being studied,49,50 there are case reports that show an increased risk of malignancy.51 Endoscopic OCT has several roles in posttreatment surveillance. It can detect buried disease and guide further endoscopic therapy. It can also serve to confirm complete eradication of BE (negative predictive value) and extend follow-up intervals or identify areas of residual disease requiring additional therapy.

3.

Endoscopic Optical Coherence Tomography Utilization in the Gastrointestinal Tract

Over the past decade, the majority of endoscopic OCT clinical studies have been performed in the esophagus due to the availability of a commercial system, and comparatively fewer studies have been performed in other areas of the GI tract, such as the stomach, duodenum, bile duct, and colon. This section will describe recent representative studies conducted using the state-of-the-art endoscopic OCT systems for the esophagus as examples of clinical use, followed by a highlight of studies conducted in other areas of the GI tract.

3.1.

Structural Features for Dysplasia Detection in the Esophagus

As with any new imaging modality, early investigations using OCT were focused on the structural features corresponding to pathology and evaluating the subsurface and high-resolution imaging capabilities. Early studies in the 2000s demonstrated that endoscopic OCT can be used to detect metaplasia in BE patients.52,53 In a 55-patient study, Evans et al.54 described structural features including layered architecture, glands, and surface maturation based on OCT image features and developed the criteria to differentiate IMC and HGD from LGD, indeterminate-grade dysplasia (IGD), and SIM with no dysplasia with 83% sensitivity and 75% specificity. This study along with the introduction of high-speed endoscopic balloon-based OCT systems27 demonstrated the feasibility for clinical esophageal applications and laid down the foundation for commercialization of GI-focused OCT systems. Commercialization enabled broad access to this technology and thereby increased the number of users and patients in both a research and routine clinical setting.

Following the probe-based OCT imaging systems by Imalux Corporation and Lightlab Imaging for general and cardiovascular imaging applications, respectively, the first commercial endoscopic OCT system developed specifically for GI applications was the NvisionVLE® Imaging System, developed by NinePoint Medical™, Inc., now known as volumetric laser endomicroscopy (VLE).51,55 The system uses a balloon-based imaging probe and can provide real-time volumetric scans from inside the esophagus covering 6 cm length with 7-μm axial resolution and up to 3-mm imaging depth in tissue. Since its launch in 2013, several multicenter and longitudinal clinical studies have been conducted. In 2016 a 1000-patient registry was completed with the participation of 18 major medical centers across the United States56 and is currently the largest database of esophageal OCT scans along with data evaluating the clinical impact of this technology. Figure 2 includes representative cross-sectional OCT images acquired by NvisionVLE systems with corresponding histology illustrating the structural difference from normal to a variety of pathologies in the esophagus. Leggett et al.57 established a diagnostic algorithm to detect dysplasia based on the VLE data from 27 patients. This step-wise method allows rating each OCT image based on mucosal layer effacement, presence of atypical glands, and surface-to-subsurface intensity ratio over a 1-cm longitudinal subset of the volumetric dataset. The workflow is shown in Fig. 3 and it is reported that the diagnostic algorithm can achieve 86% sensitivity, 88% specificity, and 87% diagnostic accuracy to detect BE dysplasia with almost perfect interobserver agreement among three raters (kappa=0.86).57 A recent independent study conducted by Swager et al.58 also reported similar VLE features (lack of layering, higher surface signal, and presence of irregular/dilated glands) significantly associated with BE neoplasia. Although these analyses were performed on ex vivo EMR samples, the feature-based diagnostic algorithm can serve as a general guideline to help in the interpretation of VLE images and potentially can be adapted in vivo with real-time interpretation performed on any regions of interest (ROI) covered by the volumetric data.

Fig. 2

Representative VLE circumferential (top), magnified (middle), and histological (bottom) images in the esophagus: (a) normal esophagus shows well-defined layered structure; (b) dysplastic BE shows loss of layering and irregular glands; (c) esophageal cancer shows loss of layering with septate cribriform glands. ep, epithelium; lp, lamina propria; mm, muscularis mucosa; sm, submucosa; mp, muscularis propria; ad, adventitia. Arrows indicate irregular glands. Scale bars in VLE images are in tissue. Images provided by NinePoint Medical.

JBO_22_12_121716_f002.png

Fig. 3

Flowchart of dysplasia diagnostic algorithm using VLE. The figure is reproduced from Ref. 57.

JBO_22_12_121716_f003.png

According to criteria set by the American Society of Gastrointestinal Endoscopy in the preservation and incorporation of valuable endoscopic innovations criteria for BE,59 any diagnostic advanced imaging tool must be validated against the histological diagnosis from such imaged locations. In addition the performance of such a tool must meet a per-patient sensitivity >90% and a negative predictive value (NPV) >98% for detecting HGD or early esophageal adenocarcinoma (EAC), as well as a sufficiently high specificity (80%) to allow a reduction of the number of biopsies compared with random biopsies. Early clinical publications that used OCT did not have the ability to provide accurate coregistration among the OCT image, the endoscopic image, and corresponding histology. It is challenging to obtain biopsies from the exact imaged locations because these two activities do not typically happen concurrently even with the use of multichannel endoscopes, especially when the ROI identified from the images are small or not superficial (e.g., a small group of subsurface atypical glands).60 Researchers have used in vivo50 or ex vivo58 methods to achieve coregistration between OCT images and histology by creating visual landmarks on surrounding tissue. Suter et al.61 demonstrated an integrated OCT system with the addition of a high-power laser that can create superficial cautery marks around the ROI during real-time OCT imaging. This combined imaging and marking method allowed for precise OCT to histology registration without the need for additional endoscopic tools, thereby allowing seamless integration into the existing clinical workflow.

This laser marking technology was integrated into the second generation of the commercial NvisionVLE system with Real-time Targeting™ and was launched in 2016. The first-in-human study using this system was conducted by Swager et al.62 In this 16-patient study, the main goal was to evaluate the visibility and locational accuracy of the laser marks made by the system across different tissue types in the esophagus including normal, nondysplastic Barrett’s esophagus, LGD, HGD, and early EAC. Figure 4 shows an example of the laser marking workflow, where the VLE balloon probe is deployed at the gastroesophageal junction (GEJ), ROIs are identified and marked with the system, and reidentified under WLE. Overall the visibility of laser marks under WLE was high, with 92% in gastric mucosa, 100% in BE mucosa, and 97% in squamous mucosa.62 It is also reported that 100% of suspicious regions identified in OCT images were successfully targeted by the laser marks, which allowed biopsy or EMR at the targeted regions. This study demonstrated the feasibility of laser marking-guided biopsy and subsequent tissue retrieval, which can achieve accurate image and tissue coregistration for future OCT clinical studies. More importantly for routine clinical use, this new advancement shows the potential to improve the diagnostic yield and address the major unmet need of current endoscopic practice.

Fig. 4

Integrated real-time laser marking functionality allows coregistration of endoscopic OCT images and histology. The figure is reproduced from Ref. 62.

JBO_22_12_121716_f004.png

Esophageal squamous cell carcinoma (SCC) is another type of esophageal cancer that has increasing prevalence in Asia.63 Hatta et al.64,65 conducted multiple clinical studies with over a hundred patients enrolled and utilized OCT to assess the tumor invasion in superficial SCC. In these studies, the tumor staging criteria were established based on cross-sectional OCT images, and the prospective study reported an overall accuracy of 90.1% with good interobserver agreement (κ=0.73) and showed superiority to high-resolution ultrasound for staging SCC.65 Trindade et al.66 also published a case report recently that used the NvisionVLE system to stage SCC and consequently guided the physician to select suitable endoscopic therapy. These results highlight the potential of using high-resolution and subsurface imaging capabilities from OCT to guide the assessment and management of esophageal cancer.

3.2.

Endoscopic Therapy Guidance

In addition to guided biopsy and tissue retrieval, OCT can also be used to guide endoscopic treatment and monitor the treatment efficacy. Researchers at Massachusetts Institute of Technology and VA Boston Healthcare System have conducted a comprehensive series of clinical studies that used endoscopic OCT to evaluate the treatment of BE patients with RFA. It was demonstrated that OCT can be used before the ablation to predict the treatment efficacy based on the BE mucosal thickness,67 during the ablation to monitor the depth of thermal injury,68,69 and after the ablation to evaluate tissue recovery and detection of buried glands in follow-up sessions.70 Although RFA is able to effectively treat dysplasia associated with BE,45,71,72 a 33% BE recurrence was reported in a multicenter study after 2 years of complete remission of intestinal metaplasia (CRIM) by RFA treatment.73 There are different hypotheses regarding the cause of BE recurrence, with the presence of buried glands or subsquamous intestinal metaplasia being one of them. Endoscopic OCT can potentially serve as a longitudinal monitoring tool to study the tissue changes over time after treatment. Recently, Swager et al.50 conducted a 17-patient study using VLE and reported buried Barrett’s glands (Fig. 5) in 1 out of 17 patients who had received RFA treatment and achieved CRIM. Significant potential exists for the use of OCT, as it is the only currently available imaging modality for detecting buried disease posttreatment.

Fig. 5

Endoscopic OCT allows subsurface imaging and is able to detect buried Barrett’s glands underneath normal looking esophagus: (a) in vivo OCT scan; (b) endoscopic picture with narrow-band imaging showing no residual BE within the neosquamous epithelium; (c) WLE image of the site after endoscopic resection; (d) buried Barrett’s glands on the in vivo OCT image; (e) buried Barrett’s glands on the ex vivo OCT image; (f) corresponding histology. Arrowheads indicate buried Barrett’s glands and asterisk indicates blood vessel. Originally published in Ref. 50.

JBO_22_12_121716_f005.png

3.3.

Barrett’s Esophagus Screening Using Optical Coherence Tomography

The prevalence of BE is estimated to be 5.6% of the general US population74 with such individuals having a significantly higher risk of developing esophageal adenocarcinoma.75,76 However, the majority of people with BE are asymptomatic77 and early detection in the form of a screening test is difficult. The introduction of a tethered OCT capsule in 2013 created significant excitement for endoscopic OCT in the esophagus.28 The capsule (12  mm in diameter) allows direct deployment of the optics through swallowing and enables high-resolution circumferential OCT imaging of the esophagus. The fact that it does not require sedation or anesthesia, unlike standard endoscopic procedures, and can provide subsurface structural information makes this technology a promising BE screening tool. This first version performs 2-D cross-sectional imaging and requires longitudinal manipulation from the proximal end to achieve volumetric imaging of the esophagus. To date, this OCT capsule has been used in clinical studies in >100 patients78,79 with early results demonstrating feasibility, high patient acceptability, and strong potential for clinical impact. With the use of a micromotor and pneumatic translation mechanism, Liang et al.80,81 developed a capsule probe design (Fig. 6) that enabled precise rotary and longitudinal scanning and demonstrated high speed (250 fps), high-quality volumetric imaging along with en face visualization with minimized distortion caused by motion.

Fig. 6

Tethered capsule with en face imaging using pneumatic longitudinal translation: (a) schematic of the device; (b, c) photographs of the device with motor carriage at beginning and ending of longitudinal positions, respectively; (d) en face OCT image of swine rectum at 400-μm depth from the surface. Scale bar: 1 mm. Originally published in Ref. 80.

JBO_22_12_121716_f006.png

The tethered capsule OCT imaging technology in combination with the previously mentioned OCT diagnostic criteria could be used to screen a targeted population and identify patients at highest risk of cancer that would benefit from endoscopic therapy. To gain clinical acceptance, this technology needs to be cost effective, easily operated, and capable of providing quick results.

3.4.

Inflammatory Bowel Disease and Polyps Screening Investigation in Colon

Outside of the esophagus, the colon is the most studied organ in the GI tract using OCT. Colorectal cancer is the second leading cause of cancer death in the US.32 Although early detection can be achieved by performing conventional colonoscopy screening, the full polypectomy procedure plus pathology lab process can be time consuming and inefficient in cases with a large number of identified polyps, especially with the majority being hyperplastic polyps. Thus, an imaging modality such as OCT that can provide broad field, subsurface, and near-microscopic imaging capabilities could be used to prescreen the polyps or suspicious regions and help guide treatment.

Several in vivo studies have been conducted to study the structural difference between colorectal cancer and adenomatous polyps,82,83 as well as to study the differentiation of inflammatory bowel diseases84,85 using cross-sectional OCT images. Trindade et al.86 reported the first case of the NvisionVLE system to evaluate a rectal polyp near the dentate line. Here OCT showed normal submucosa underneath the polyp, which altered the polyp management from full-thickness resection to EMR. The volumetric OCT imaging in the colon also allows visualization of en face features for better differentiation of the diseases.87 Recently, Liang et al.88 developed a forward-viewing OCT probe using a piezoelectric actuator and demonstrated high-resolution en face colon images that are analogous to magnified endoscopic view without requiring contrast agent and providing multidepth visualization. Figure 7 shows in vivo volumetric images from a hyperplastic polyp at an imaging speed of 2 volumes per second, which is an encouraging example of in vivo polyp assessment using OCT.

Fig. 7

Forward-viewing probes allow in situ polyps assessment during colonoscopy: (a) endoscopic image showing probe in contact with hyperplastic polyp; (b) cross-sectional OCT image from the polyp; (c, d) en face OCT visualization of the polyp at 40- and 200-μm depth, respectively, showing enlarged crypts. Scale bars: 100  μm. Originally published in Ref. 88.

JBO_22_12_121716_f007.png

3.5.

Visualization of Pancreatico-Biliary Tract Strictures

Bile duct strictures can be malignant (cholangiocarcinoma) or benign such as those caused by primary sclerosing cholangitis (PSC) and other conditions. Strictures can be challenging to access and to diagnose accurately. Currently, the most common way to differentiate a biliary stricture is to perform endoscopic retrograde cholangiopancreatography (ERCP) with biopsy or brush cytology.89,90 However, the diagnostic yield is low due to the small tissue sampled and torturous anatomy of the bile duct.91,92 Researchers have been evaluating endoscopic OCT to help improve the diagnostic accuracy of biliary strictures. With a low-profile OCT probe, such distant and tortuous anatomies can be imaged with high fidelity providing new insights on disease diagnosis and progression. Several preliminary clinical studies have shown that OCT can provide morphological information for biliary strictures, which can be used to differentiate malignant versus benign strictures with high accuracy.9394.95

The availability of commercialized endoscopic OCT systems has enabled the use of OCT imaging in the evaluation of indeterminate pancreatico-biliary strictures. Tyberg et al.96 conducted a 9-patient study and demonstrated that strictures with cholangiocarcinoma showed a hyperreflective surface with a loss of inner wall layering while benign biliary strictures showed clear delineated ductal wall layering. Joshi et al.97 also conducted a 22-patient study that came to similar conclusions, and performed quantification analysis on the thickness of each layer to identify the key features to differentiate benign, inflammatory, and malignant tissue types in the bile duct. Figure 8 shows examples of in vivo OCT images in the biliary duct including normal, PSC, and cholangiocarcinoma using the NvisionVLE system with low-profile OCT probes. These studies show that OCT is feasible and has the potential to improve the sensitivity of diagnosing indeterminate strictures.

Fig. 8

Representative VLE (top) and histological (bottom) images in the biliary duct: (a) normal bile duct; (b) PSC shows in-tact wall layering, “onion-skin” structure, and subsurface hyperreflective regions; (c) cholangiocarcinoma shows hyperreflective surface, loss of ductal wall layering and image penetration, and thickened luminal debris and/or epithelial projections. Courtesy of Dr. Virendra Joshi at Ochsner Clinic Foundation, Dr. Douglas Pleskow at Beth Israel Deaconess Medical Center, and Dr. Isaac Raijman at Baylor College of Medicine.

JBO_22_12_121716_f008.png

3.6.

Gastric Lesions Evaluation

While the majority of OCT studies focused on the esophagus, there are few studies that describe the general structural difference between disease and normal tissue in the stomach. These include incidental examples that were obtained within GI OCT studies and single case report-based findings that specifically focused on gastric lesions. Recently Xu et al.98 conducted a 5-patient case study using a commercial NvisionVLE system to identify structural features associated with intestinal metaplasia, LGD, HGD, and submucosal tumor (Fig. 9). Different from the well-defined layered architecture in the esophagus, the cardia has signature “pits and crypts” appearance under OCT cross-sectional images, which potentially can be used as one of the features to differentiate gastric lesions. Using ultrahigh-speed endoscopic OCT with distal motor based scanning probe, Lee et al.99,100 reported the en face OCT findings from patients with gastric antral vascular ectasia (a cause of upper GI bleeding) before and after RFA treatment, which highlighted the potential for OCT to evaluate response to treatment.

Fig. 9

OCT findings in normal and diseased gastric tissue: (a) normal gastric tissue has a regular foveolar appearance with characteristic “pits” and “crypts” presenting as superficial striations in the image; (b) in focal intestinal metaplasia shows a disruption to the normal pits and crypts structure along with increased surface reflectivity; (c) gastric adenoma presents as a loss of pit and crypt structure with a proliferation of clustered, dilated atypical glands; (d) NET of the stomach presents as a loss of pit and crypt structure with a distinct, low scattering submucosal structure, clearly delineated from surrounding tissue. Original published in Ref. 98.

JBO_22_12_121716_f009.png

3.7.

Disease Research in the Small Intestine

Compared with the rest of the GI tract, the small intestine is the most challenging anatomy for OCT, or any other endoscopic modality, due to its lengthy and torturous anatomy, and thus the least investigated organ of the GI tract. Most early studies were conducted in the duodenum, the most proximal section of the small intestine, focusing on the detection of celiac disease and Crohn’s disease. Celiac disease is an autoimmune disease of the small intestine induced by ingestion of gluten, which leads to the damage of villi ultimately affecting the absorption of nutrients. Since the current standard of care for celiac disease is to confirm a diagnosis pathologically with duodenal biopsies, it also suffers from sampling limitations and thus researchers have been seeking alternative tools including OCT to achieve a more accurate diagnosis. A series of OCT studies conducted by Masci et al.101,102 showed that OCT can be used to effectively differentiate celiac disease based on the OCT findings of villous atrophy. Kamboj et al.103 reported the first case of the NvisionVLE system to identify the structural features of a duodenal neuroendocrine tumor (NET), which revealed an asymmetric submucosal mass with septated regions of high and low signal intensity corresponding to a well-circumscribed mass with multiple lobules separated by fibrous septa from the matching histology. Figure 10 shows another example of OCT applications at the other end of the small intestine, the terminal ileum (TI).90 Recently, Lee et al.104 used an ultrahigh-speed endoscopic OCT system to study the structural difference of Crohn’s disease in the TI compared with a healthy control, and showed the TI with Crohn’s ileitis exhibited irregular mucosal patterns and enlarged villi internal structures, suggesting OCT could also be a promising tool for disease diagnosis in the small intestine.

Fig. 10

Volumetric OCT of the terminal ileum: (a) en face OCT image at 50-μm depth shows typical villi structure. The inset shows the endoscopic view of the terminal ileum with the OCT imaging catheter in contact with the ileum wall; (b) en face OCT image at 300-μm depth shows numerous glandular structures under the tissue surface; (c) cross-sectional image along the pullback direction; (d) cross-sectional image along the rotary direction; (e) corresponding biopsy histology of the terminal ileum. Red arrow: ileum glands. Blue arrows: Peyer’s patches. Originally published in Ref. 99.

JBO_22_12_121716_f010.png

4.

New Technologies and Future Applications

In addition to the GI clinical activities with the use of state-of-the-art endoscopic OCT, there are several technologies that have been developed and could be easily integrated with OCT to achieve better performance or provide additional functionality. This section will discuss a few examples and the new opportunities for GI applications with the use of these integrated/advanced OCT technologies.

4.1.

Endoscopic Optical Coherence Tomography Angiography for Microvasculature Visualization

Vascular patterns on the surface of a lesion are another important indicator in detecting dysplasia in the GI tract. Imaging technologies that can enhance the surface vascular contrast, such as chromoendoscopy or NBI combined with magnification endoscopy, have been demonstrated to provide high sensitivity for detection of HGD.34,105 Phase or intensity variation-based OCT techniques have been developed to image microvasculature networks without the need for exogenous contrast agents,106107.108.109.110.111.112 but these techniques were challenging to implement in a probe-based OCT setting because dense sampling and high frame-to-frame scanning stability is critical to resolve the microvasculature with high sensitivity. The ultrahigh-speed endoscopic OCT system with a distal scanning probe was able to overcome these challenges and Tsai et al.113 reported the first human OCT angiography (OCTA) of the GI tract that revealed clear differentiation of microvasculature between normal tissue and BE (Fig. 11). The system was later used to conduct a series of clinical studies, including a 52-patient study to investigate the microvasculature features associated with dysplastic BE,114 opening up a new regime for endoscopic OCT-based research.

Fig. 11

OCT angiography reveals microvasculature in normal and BE: (a) en face intensity image at the imaging depth of 240  μm of the normal esophagus, corresponding to the lamina propria layer; (b) OCT angiogram in the same layer significantly enhances the contrast of the microvasculature in lamina propria; (c) en face intensity image at the imaging depth of 220  μm of a nondysplastic BE, corresponding to the lamina propria layer; (d) OCT angiogram in the same layers shows dense vascular structure along the squamous–columnar junction, which may be an indication of BE progression. Originally published in Ref. 113.

JBO_22_12_121716_f011.png

4.2.

Optical Coherence Elastography for Quantifying Tissue Mechanical Properties

High speed and high resolution allows OCT to visualize small displacements of tissue due to external forces, and can be used to quantify mechanical properties, such as strain and elasticity.115,116 With disease progression, mechanical properties of tissue can change due to different cell type composition. Researchers have developed OCT-based methods to quantify these changes, namely optical coherence elastography (OCE).117 Most of the development efforts focused on the methods to induce tissue displacement effectively, and to develop signal processing algorithms to optimize sensitivity,118119.120 OCE was used to study human breast tumor,121 and assess breast cancer margins122 with promising early results. Probe-based OCE has been demonstrated in a forward-viewing configuration mainly due to the need to introduce tissue displacement with the probe contact.123,124 This requirement may limit the endoscopic OCE applications to be point-based examination, but further research and innovation are needed.

4.3.

Polarization-Sensitive Optical Coherence Tomography Provides Additional Tissue Contrast

Polarization-sensitive OCT (PS-OCT) can measure the change in polarization as light penetrates tissue with birefringence125,126 and has been broadly used in free-space bench-top applications such as ophthalmology to study the birefringence properties of biological tissues.127128.129.130 To be used in fiber optics probe-based OCT applications, researchers have developed several solutions to correct the change of polarization state within the probes by modulating the polarization modulation in the OCT interferometer.131132.133 Probe-based PS-OCT has been utilized clinically in cardiology134 and pulmonology,135 and shown to clearly reveal additional tissue contrast such as collagen fibers and smooth muscle on top of the OCT structural images. Although there currently are no publications demonstrating in vivo PS-OCT data from the GI tract, the capability to highlight muscular structures is a relevant addition to intensity-based OCT images, as the distribution of muscularis mucosa is another indicator to differentiate disease in the GI tract. Although muscularis mucosa is typically a thin layer between the lamina propria and submucosa, it is sometimes challenging to delineate the muscularis mucosa layer simply based on the intensity images, so PS-OCT may provide more comprehensive information for disease diagnosis.

Figure 12 shows in vivo endoscopic PS-OCT images from a recent unpublished study in swine, using a modified NvisionVLE imaging system. By modulating the polarization states of consecutive sweeps from the SS and calculating the Stokes vectors rotation adopted from the methods described in Ref. 132, local retardation (LR, represents birefringence of the tissue) and degree of polarization uniformity (DOPU, represents scattering from tissue structure) were measured in a live swine esophagus. From the LR image, the layers consist of muscle fiber, including muscularis mucosa and muscularis propria, showing higher local retardation values corresponding to higher birefringence. Connective tissue layers including lamina propria and submucosa show relatively low LR values, and the epithelium layer basically presents no LR. From the DOPU image, epithelium, lamina propria, and submucosa layers show high uniformity, whereas the muscle layers show more depolarization nature. This result demonstrates that PS-OCT offers birefringence contrast of the GI tract in an in vivo endoscopic setting and may become important for tissue differentiation.

Fig. 12

In vivo swine esophagus images using probe-based polarization sensitive OCT: (a) intensity image shows well-defined layered structure in the normal swine esophagus; (b) corresponding histology from the imaged location; (c) intensity mapped local retardation image highlights the layers containing muscle fibers; (d) intensity mapped degree of polarization uniformity shows lower polarization uniformity in muscle layers. The color scales from 0 to 1.5  deg/μm for local retardation image and 0.5 to 1 for degree of polarization uniformity, respectively. ep, epithelium; lp, lamina propria; mm, muscularis mucosa; sm, submucosa; mp, muscularis propria. Scale bar: 1 mm. Images provided by NinePoint Medical.

JBO_22_12_121716_f012.png

4.4.

Multimodality Systems for Functional Imaging

In addition to OCT-derivative technologies, the compact form factor of fiber-optics based probe allows easy integration of endoscopic OCT with other modalities and tools. Ultrasound has the advantage of deeper imaging penetration in tissue and is suitable for applications that require morphological information on a larger scale, such as cancer staging.136 The integration of OCT and ultrasound can provide a full portfolio of tissue structural information and has been demonstrated in cardiovascular applications in miniaturized probe-based settings,137,138 so it would be feasible to apply the technology for GI imaging. Due to generally larger lumen size in the GI tract, the OCT/ultrasound probe will either operate directly in contact with the tissue or in an index-matching condition to minimize the ultrasonic signal saturation from the tissue/air interface. Similar to ultrasound, photoacoustic tomography (PAT) detects laser-induced ultrasound waves from the tissue and is extremely sensitive to optical absorbers such as hemoglobin and melanin, so it is an ideal tool to see the blood vessels. Combined PAT and OCT systems have been demonstrated in dermatological applications139,140 and realized in probe format for endoscopic applications.141,142 PAT can also be used to quantify hemodynamic functions such as oxygen saturation and hemoglobin concentration, which can serve as a potential biomarker for disease differentiation.143,144

The use of fiber optics allows transmitting light with different wavelengths simultaneously and thus fluorescence imaging is another modality that can operate alongside OCT. Fluorescent contrasts offer molecular information from the tissue complementary to OCT’s structural information and thus could improve the specificity. Various research groups have demonstrated the feasibility of combined fluorescence and OCT imaging in probe-based settings in pulmonary nodule detection,145,146 coronary artery disease assessment,147148.149 vasculature detection in the esophagus,150 and fundamental biology research.151

As endoscopic OCT is able to guide tissue sampling and therapy, it makes sense to integrate with other endoscopic tools such as tissue retrieval and ablation devices. Feasibility demonstrations of probe-based OCT with aspiration needles for pulmonary application have been shown,152153.154 as well as laser coagulation155 and RFA69 devices. Although there is more work to be done for the GI application space, the integration of OCT and endoscopic tools is envisioned to help simplify the clinical workflow and greatly improve the diagnostic and treatment efficacy.

5.

Outlook of Endoscopic Optical Coherence Tomography

Endoscopic OCT has grown significantly over the past decade and there are many opportunities not yet fully explored in the GI space. With its high resolution, wide-area, subsurface imaging capabilities, endoscopic OCT has the potential to provide solutions to significant unmet needs in the gastroenterology practice including targeted tissue sampling as well as integration with therapy to increase diagnostic yield, guiding more effective treatment and monitoring progression of disease post treatment.

As with all new technologies, a period of investigation to evaluate the utility is followed by a period of consolidation to implement standardized techniques and workflow within a routine clinical setting. For endoscopic applications of OCT, image interpretation poses the greatest level of effort in this standardization process. As the technology is more widely accessible, such as the case with esophageal OCT imaging, studies investigating the relationship between image features and the underlying pathology, development of clinically relevant algorithms for diagnosis of specific conditions, and finally standardized methods for training and dissemination are ongoing.53,57,114,156,157

With the advancement of image processing and machine learning techniques, the ability to perform real-time automated detection and diagnosis of suspicious regions within these large volumetric OCT datasets is now within reach. Recently, multiple groups have published such computer-aided algorithms for detection of esophageal diseases using OCT158159.160.161.162 and demonstrated high diagnostic accuracy. Figure 13 shows an example machine learning algorithm that can identify specific OCT image features within the esophagus, including tissue surface hyperreflectivity, layering, and hyporeflective structures. We believe that further research and development in this field will transform OCT into a routine clinical tool for real-time disease guidance and management.

Fig. 13

An example machine learning algorithm identifying specific OCT image features within the esophagus, including tissue surface hyperreflectivity, layering, and hyporeflective structures. (a) Cross-sectional view shows all three features highlighted. (b) Luminal view shows the features overlaid on the volumetric dataset. Images provided by NinePoint Medical.

JBO_22_12_121716_f013.png

In conclusion, endoscopic OCT is a unique technology that provides high resolution, minimally invasive optical sectioning in 3-D while being able to support broad imaging coverage. Collaboration and innovation from both academia and industry have contributed to the commercialization of this technology, with continued effort we believe endoscopic OCT will further advance the gastroenterology practice and improve patient quality of life.

Disclosures

T.-H. Tsai and E. Namati are under direct employment of NinePoint Medical, Inc. All other authors disclosed no financial relationships relevant to this publication.

Acknowledgments

The authors would like to thank the clinical, marketing, and R&D team members of NinePoint Medical for preparing some of the publication figures.

References

1. E. Seward and S. Lumley, “Endoscopy provision: meeting the challenges,” Frontline Gastroenterol. 8(2), 90–93 (2017). http://dx.doi.org/10.1136/flgastro-2016-100764 Google Scholar

2. N. Kurniawan and M. Keuchel, “Flexible gastro-intestinal endoscopy—clinical challenges and technical achievements,” Comput. Struct. Biotechnol. J. 15, 168–179 (2017). http://dx.doi.org/10.1016/j.csbj.2017.01.004 Google Scholar

3. D. Huang et al., “Optical coherence tomography,” Science 254(5035), 1178–1181 (1991).SCIEAS0036-8075 http://dx.doi.org/10.1126/science.1957169 Google Scholar

4. G. J. Tearney et al., “In vivo endoscopic optical biopsy with optical coherence tomography,” Science 276(5321), 2037–2039 (1997).SCIEAS0036-8075 http://dx.doi.org/10.1126/science.276.5321.2037 Google Scholar

5. E. A. Swanson et al., “In vivo retinal imaging by optical coherence tomography,” Opt. Lett. 18(21), 1864–1866 (1993).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.18.001864 Google Scholar

6. A. F. Fercher et al., “Measurement of intraocular distances by backscattering spectral interferometry,” Opt. Commun. 117(1–2), 43–48 (1995).OPCOB80030-4018 http://dx.doi.org/10.1016/0030-4018(95)00119-S Google Scholar

7. B. Cense et al., “Ultrahigh-resolution high-speed retinal imaging using spectral-domain optical coherence tomography,” Opt. Express 12(11), 2435–2447 (2004).OPEXFF1094-4087 http://dx.doi.org/10.1364/OPEX.12.002435 Google Scholar

8. M. Wojtkowski et al., “Ophthalmic imaging by spectral optical coherence tomography,” Am. J. Ophthalmol. 138(3), 412–419 (2004).AJOPAA0002-9394 http://dx.doi.org/10.1016/j.ajo.2004.04.049 Google Scholar

9. K. Takada et al., “New measurement system for fault location in optical waveguide devices based on an interferometric technique,” Appl. Opt. 26(9), 1603–1608 (1987).APOPAI0003-6935 http://dx.doi.org/10.1364/AO.26.001603 Google Scholar

10. H. H. Gilgen et al., “Submillimeter optical reflectometry,” IEEE J. Lightwave Technol. 7(8), 1225–1233 (1989). http://dx.doi.org/10.1109/50.32387 Google Scholar

11. E. A. Swanson et al., “High-speed optical coherence domain reflectometry,” Opt. Lett. 17(2), 151–153 (1992).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.17.000151 Google Scholar

12. M. A. Choma et al., “Sensitivity advantage of swept source and Fourier domain optical coherence tomography,” Opt. Express 11(18), 2183–2189 (2003).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.11.002183 Google Scholar

13. J. F. de Boer et al., “Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography,” Opt. Lett. 28(21), 2067–2069 (2003).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.28.002067 Google Scholar

14. R. Leitgeb, C. K. Hitzenberger and A. F. Fercher, “Performance of Fourier domain vs. time domain optical coherence tomography,” Opt. Express 11(8), 889–894 (2003).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.11.000889 Google Scholar

15. N. Nassif et al., “In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography,” Opt. Lett. 29(5), 480–482 (2004).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.29.000480 Google Scholar

16. S. R. Chinn, E. A. Swanson and J. G. Fujimoto, “Optical coherence tomography using a frequency-tunable optical source,” Opt. Lett. 22(5), 340–342 (1997).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.22.000340 Google Scholar

17. S. H. Yun et al., “High-speed wavelength-swept semiconductor laser with a polygon-scanner-based wavelength filter,” Opt. Lett. 28(20), 1981–1983 (2003).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.28.001981 Google Scholar

18. T. H. Ko et al., “Ultrahigh resolution optical coherence tomography imaging with a broadband superluminescent diode light source,” Opt. Express 12(10), 2112–2119 (2004).OPEXFF1094-4087 http://dx.doi.org/10.1364/OPEX.12.002112 Google Scholar

19. F. E. Robles, S. Chowdhury and A. Wax, “Assessing hemoglobin concentration using spectroscopic optical coherence tomography for feasibility of tissue diagnostics,” Biomed. Opt. Express 1(1), 310–317 (2010).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.1.000310 Google Scholar

20. B. J. Vakoc et al., “Comprehensive esophageal microscopy by using optical frequency-domain imaging (with video),” Gastrointest. Endoscopy 65(6), 898–905 (2007). http://dx.doi.org/10.1016/j.gie.2006.08.009 Google Scholar

21. D. C. Adler et al., “Three-dimensional endomicroscopy using optical coherence tomography,” Nat. Photonics 1(12), 709–716 (2007).NPAHBY1749-4885 http://dx.doi.org/10.1038/nphoton.2007.228 Google Scholar

22. T.-H. Tsai et al., “Piezoelectric-transducer-based miniature catheter for ultrahigh-speed endoscopic optical coherence tomography,” Biomed. Opt. Express 2(8), 2438–2448 (2011).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.2.002438 Google Scholar

23. W. Wieser et al., “Multi-megahertz OCT: high quality 3D imaging at 20 million A-scans and 4.5 GVoxels per second,” Opt. Express 18(14), 14685–14704 (2011).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.18.014685 Google Scholar

24. T. Wang et al., “Heartbeat OCT and motion-free 3D in vivo coronary artery microscopy,” JACC: Cardiovasc. Imaging 9(5), 622 (2016). http://dx.doi.org/10.1016/j.jcmg.2015.08.010 Google Scholar

25. T.-H. Tsai, J. Fujimoto and H. Mashimo, “Endoscopic optical coherence tomography for clinical gastroenterology,” Diagnostics 4(2), 57–93 (2014). http://dx.doi.org/10.3390/diagnostics4020057 Google Scholar

26. M. J. Gora et al., “Endoscopic optical coherence tomography: technologies and clinical applications [Invited],” Biomed. Opt. Express 8(5), 2405–2444 (2017).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.8.002405 Google Scholar

27. M. J. Suter et al., “Comprehensive microscopy of the esophagus in human patients with optical frequency domain imaging,” Gastrointest. Endoscopy 68(4), 745–753 (2008). http://dx.doi.org/10.1016/j.gie.2008.05.014 Google Scholar

28. M. J. Gora et al., “Tethered capsule endomicroscopy enables less invasive imaging of gastrointestinal tract microstructure,” Nat. Med. 19(2), 238–240 (2013).1078-8956 http://dx.doi.org/10.1038/nm.3052 Google Scholar

29. Y. T. Pan, H. K. Xie and G. K. Fedder, “Endoscopic optical coherence tomography based on a microelectromechanical mirror,” Opt. Lett. 26(24), 1966–1968 (2001).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.26.001966 Google Scholar

30. E. J. Seibel and Q. Y. J. Smithwick, “Unique features of optical scanning, single fiber endoscopy,” Lasers Surg. Med. 30(3), 177–183 (2002).LSMEDI0196-8092 http://dx.doi.org/10.1002/(ISSN)1096-9101 Google Scholar

31. S. Moon et al., “Semi-resonant operation of a fiber-cantilever piezotube scanner for stable optical coherence tomography endoscope imaging,” Opt. Express 18(20), 21183–21197 (2010).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.18.021183 Google Scholar

32. American Cancer Society, “Cancer facts and figures—2017,” American Cancer Society, Atlanta (2017). Google Scholar

33. S. E. Kudo et al., “Diagnosis of colorectal tumorous lesions by magnifying endoscopy,” Gastrointest. Endoscopy 44(1), 8–14 (1996). http://dx.doi.org/10.1016/S0016-5107(96)70222-5 Google Scholar

34. P. Sharma et al., “The utility of a novel narrow band imaging endoscopy system in patients with Barrett’s esophagus,” Gastrointest. Endoscopy 64(2), 167–175 (2006). http://dx.doi.org/10.1016/j.gie.2005.10.044 Google Scholar

35. R. F. Souza, C. P. Morales and S. J. Spechler, “Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett’s oesophagus,” Aliment. Pharmacol. Ther. 15(8), 1087–1100 (2001).APTHEN1365-2036 http://dx.doi.org/10.1046/j.1365-2036.2001.01046.x Google Scholar

36. A. P. Weston et al., “p53 protein overexpression in low grade dysplasia (LGD) in Barrett’s esophagus: immunohistochemical marker predictive of progression,” Am. J. Gastroenterol. 96(5), 1355–1362 (2001). http://dx.doi.org/10.1111/j.1572-0241.2001.03851.x Google Scholar

37. N. J. Shaheen et al., “ACG clinical guideline: diagnosis and management of Barrett’s esophagus,” Am. J. Gastroenterol. 111(1), 30–50 (2016). http://dx.doi.org/10.1038/ajg.2015.322 Google Scholar

38. P. T. Chandrasoma and T. R. DeMeester, GERD: Reflux to Esophageal Adenocarcinoma, Elsevier Science (2010). Google Scholar

39. H. Mashimo, M. S. Wagh and R. K. Goyal, “Surveillance and screening for Barrett esophagus and adenocarcinoma,” J. Clin. Gastroenterol. 39(4), S33–S41 (2005). http://dx.doi.org/10.1097/01.mcg.0000155859.26557.45 Google Scholar

40. M. A. Anderson et al., “Complications of ERCP,” Gastrointest. Endoscopy 75(3), 467–473 (2012). http://dx.doi.org/10.1016/j.gie.2011.07.010 Google Scholar

41. H. Inoue and M. Endo, “Endoscopic esophageal mucosal resection using a transparent tube,” Surg. Endoscopy 4(4), 198–201 (1990). http://dx.doi.org/10.1007/BF00316791 Google Scholar

42. T. Oyama et al., “Endoscopic submucosal dissection of early esophageal cancer,” Clin. Gastroenterol. Hepatol. 3(7, Suppl. 1), S67–S70 (2005). http://dx.doi.org/10.1016/S1542-3565(05)00291-0 Google Scholar

43. M. Hirao et al., “Endoscopic resection of early gastric cancer and other tumors with local injection of hypertonic saline-epinephrine,” Gastrointest. Endoscopy 34(3), 264–269 (1988). http://dx.doi.org/10.1016/S0016-5107(88)71327-9 Google Scholar

44. K. E. Grund, D. Storek and G. Farin, “Endoscopic argon plasma coagulation (APC) first clinical experiences in flexible endoscopy,” Endoscopic Surg. Allied Technol. 2(1), 42–46 (1994). Google Scholar

45. N. J. Shaheen et al., “Radiofrequency ablation in Barrett’s esophagus with dysplasia,” New Engl. J. Med. 360(22), 2277–2288 (2009).NEJMBH http://dx.doi.org/10.1056/NEJMoa0808145 Google Scholar

46. M. H. Johnston et al., “Cryoablation of Barrett’s esophagus: a pilot study,” Gastrointest. Endoscopy 62(6), 842–848 (2005). http://dx.doi.org/10.1016/j.gie.2005.05.008 Google Scholar

47. S. Friedland and G. Triadafilopoulos, “A novel device for ablation of abnormal esophageal mucosa (with video),” Gastrointest. Endoscopy 74(1), 182–188 (2011). http://dx.doi.org/10.1016/j.gie.2011.03.1119 Google Scholar

48. K. K. Wang and R. E. Sampliner, “Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus,” Am. J. Gastroenterol. 103(3), 788–797 (2008). http://dx.doi.org/10.1111/ajg.2008.103.issue-3 Google Scholar

49. T.-H. Tsai et al., “Length of proximal extent of subsquamous intestinal metaplasia correlates with difficult eradication of Barrett esophagus by radiofrequency ablation,” Gastroenterology 144(5), S-174 (2013).GASTAB0016-5085 http://dx.doi.org/10.1016/S0016-5085(13)60621-6 Google Scholar

50. A. F. Swager et al., “Detection of buried Barrett’s glands after radiofrequency ablation with volumetric laser endomicroscopy,” Gastrointest. Endoscopy 83(1), 80–88 (2016). http://dx.doi.org/10.1016/j.gie.2015.05.028 Google Scholar

51. C. L. Leggett et al., “Volumetric laser endomicroscopy detects subsquamous Barrett’s adenocarcinoma,” Am. J. Gastroenterol. 109(2), 298–299 (2014). http://dx.doi.org/10.1038/ajg.2013.422 Google Scholar

52. J. M. Poneros et al., “Diagnosis of specialized intestinal metaplasia by optical coherence tomography,” Gastroenterology 120(1), 7–12 (2001).GASTAB0016-5085 http://dx.doi.org/10.1053/gast.2001.20911 Google Scholar

53. J. A. Evans et al., “Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography,” Gastrointest. Endoscopy 65(1), 50–56 (2007). http://dx.doi.org/10.1016/j.gie.2006.04.027 Google Scholar

54. J. A. Evans et al., “Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett’s esophagus,” Clin. Gastroenterol. Hepatol. 4(1), 38–43 (2006). http://dx.doi.org/10.1016/S1542-3565(05)00746-9 Google Scholar

55. A. J. Trindade, A. S. Vamadevan and D. V. Sejpal, “Finding a needle in a haystack: use of volumetric laser endomicroscopy in targeting focal dysplasia in long-segment Barrett’s esophagus,” Gastrointest. Endoscopy 82(4), 756–757 (2015). http://dx.doi.org/10.1016/j.gie.2015.03.1984 Google Scholar

56. M. S. Smith et al., “Volumetric laser endomicroscopy improves patient management by enhancing detection and sampling of esophageal histopathology: results from the interim analysis of a multi-center registry,” Gastroenterology 150(4), S55–S56 (2016).GASTAB0016-5085 http://dx.doi.org/10.1016/S0016-5085(16)30310-9 Google Scholar

57. C. L. Leggett et al., “Comparative diagnostic performance of volumetric laser endomicroscopy and confocal laser endomicroscopy in the detection of dysplasia associated with Barrett’s esophagus,” Gastrointest. Endoscopy 83(5), 880–888 (2016). Google Scholar

58. A.-F. Swager et al., “Identification of volumetric laser endomicroscopy features predictive for early neoplasia in Barrett’s esophagus using high-quality histological correlation,” Gastrointest. Endoscopy 85(5), 918–926 (2017). http://dx.doi.org/10.1016/j.gie.2016.09.012 Google Scholar

59. P. Sharma et al., “The American society for gastrointestinal endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett’s esophagus,” Gastrointest. Endoscopy 76(2), 252–254 (2012). http://dx.doi.org/10.1016/j.gie.2012.05.007 Google Scholar

60. M. J. Bartel et al., “Subsquamous intestinal metaplasia is common in treatment-naïve Barrett’s esophagus,” Gastrointest. Endoscopy (2017). Google Scholar

61. M. J. Suter et al., “Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine,” Gastrointest. Endoscopy 71(2), 346–353 (2010). http://dx.doi.org/10.1016/j.gie.2009.07.007 Google Scholar

62. A. F. Swager et al., “Feasibility of laser marking in Barrett’s esophagus with volumetric laser endomicroscopy: first-in-man pilot study,” Gastrointest. Endoscopy 86(3), 464–472 (2017). http://dx.doi.org/10.1016/j.gie.2017.01.030 Google Scholar

63. L. A. Torre et al., “Global cancer statistics, 2012,” CA: Cancer J. Clin. 65(2), 87–108 (2015). http://dx.doi.org/10.3322/caac.21262 Google Scholar

64. W. Hatta et al., “Optical coherence tomography for the staging of tumor infiltration in superficial esophageal squamous cell carcinoma,” Gastrointest. Endoscopy 71(6), 899–906 (2010). http://dx.doi.org/10.1016/j.gie.2009.11.052 Google Scholar

65. W. Hatta et al., “A prospective comparative study of optical coherence tomography and EUS for tumor staging of superficial esophageal squamous cell carcinoma,” Gastrointest. Endoscopy 76(3), 548–555 (2012). http://dx.doi.org/10.1016/j.gie.2012.05.012 Google Scholar

66. A. J. Trindade et al., “Use of volumetric laser endomicroscopy in staging multifocal superficial squamous carcinoma of the esophagus,” Gastrointest. Endoscopy 84(2), 369 (2016). http://dx.doi.org/10.1016/j.gie.2016.03.780 Google Scholar

67. T.-H. Tsai et al., “Structural markers observed with endoscopic 3-dimensional optical coherence tomography correlating with Barrett’s esophagus radiofrequency ablation treatment response,” Gastrointest. Endoscopy 76(6), 1104–1112 (2012). http://dx.doi.org/10.1016/j.gie.2012.05.024 Google Scholar

68. T.-H. Tsai et al., “Comparison of tissue architectural changes between radiofrequency ablation and cryospray ablation in Barrett’s esophagus using endoscopic three-dimensional optical coherence tomography,” Gastroenterol. Res. Pract. 2012, 1–8 (2012). http://dx.doi.org/10.1155/2012/684832 Google Scholar

69. H. C. Lee et al., “Assessment of the radiofrequency ablation dynamics of esophageal tissue with optical coherence tomography,” J. Biomed. Opt. 22(7), 076001 (2017).JBOPFO1083-3668 http://dx.doi.org/10.1117/1.JBO.22.7.076001 Google Scholar

70. C. Zhou et al., “Characterization of buried glands before and after radiofrequency ablation by using 3-dimensional optical coherence tomography (with videos),” Gastrointest. Endoscopy 76(1), 32–40 (2012). http://dx.doi.org/10.1016/j.gie.2012.02.003 Google Scholar

71. D. E. Fleischer et al., “Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial,” Endoscopy 42, 781–789 (2010).ENDCAM http://dx.doi.org/10.1055/s-0030-1255779 Google Scholar

72. N. J. Shaheen et al., “Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia,” Gastroenterology 141(2), 460–468 (2011).GASTAB0016-5085 http://dx.doi.org/10.1053/j.gastro.2011.04.061 Google Scholar

73. M. Gupta et al., “Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US Multicenter Consortium,” Gastroenterology 145(1), 79-86.e71 (2013). http://dx.doi.org/10.1053/j.gastro.2013.03.008 Google Scholar

74. T. J. Hayeck et al., “The prevalence of Barrett’s esophagus in the US: estimates from a simulation model confirmed by SEER data,” Dis. Esophagus 23(6), 451–457 (2010). http://dx.doi.org/10.1111/des.2010.23.issue-6 Google Scholar

75. F. Hvid-Jensen et al., “Incidence of adenocarcinoma among patients with Barrett’s esophagus,” New England J. Med. 365(15), 1375–1383 (2011).NEJMBH http://dx.doi.org/10.1056/NEJMoa1103042 Google Scholar

76. S. Bhat et al., “Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study,” J. Natl. Cancer Institute 103(13), 1049–1057 (2011). http://dx.doi.org/10.1093/jnci/djr203 Google Scholar

77. D. K. Rex et al., “Screening for Barrett’s esophagus in colonoscopy patients with and without heartburn,” Gastroenterology 125(6), 1670–1677 (2003).GASTAB0016-5085 http://dx.doi.org/10.1053/j.gastro.2003.09.030 Google Scholar

78. M. J. Gora et al., “Imaging the upper gastrointestinal tract in unsedated patients using tethered capsule endomicroscopy,” Gastroenterology 145(4), 723–725 (2013).GASTAB0016-5085 http://dx.doi.org/10.1053/j.gastro.2013.07.053 Google Scholar

79. M. J. Gora et al., “Tethered capsule endomicroscopy: from bench to bedside at a primary care practice,” J. Biomed. Opt. 21(10), 104001 (2016).JBOPFO1083-3668 http://dx.doi.org/10.1117/1.JBO.21.10.104001 Google Scholar

80. K. Liang et al., “Ultrahigh speed en face OCT capsule for endoscopic imaging,” Biomed. Opt. Express 6(4), 1146–1163 (2015).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.6.001146 Google Scholar

81. K. Liang et al., “Volumetric mapping of Barrett’s esophagus and dysplasia with en face optical coherence tomography tethered capsule,” Am. J. Gastroenterol. 111(11), 1664–1666 (2016). http://dx.doi.org/10.1038/ajg.2016.419 Google Scholar

82. P. R. Pfau et al., “Criteria for the diagnosis of dysplasia by endoscopic optical coherence tomography,” Gastrointest. Endoscopy 58(2), 196–202 (2003). http://dx.doi.org/10.1067/mge.2003.344 Google Scholar

83. E. Zagaynova et al., “Endoscopic OCT with forward-looking probe: clinical studies in urology and gastroenterology,” J. Biophotonics 1(2), 114–128 (2008). http://dx.doi.org/10.1002/(ISSN)1864-0648 Google Scholar

84. B. Shen et al., “In vivo colonoscopic optical coherence tomography for transmural inflammation in inflammatory bowel disease,” Clin. Gastroenterol. Hepatol. 2(12), 1080–1087 (2004). http://dx.doi.org/10.1016/S1542-3565(04)00621-4 Google Scholar

85. P. Consolo et al., “Optical coherence tomography in inflammatory bowel disease: Prospective evaluation of 35 patients,” Dis. Colon Rectum 51(9), 1374–1380 (2008). http://dx.doi.org/10.1007/s10350-008-9304-6 Google Scholar

86. A. J. Trindade et al., “Successful use of volumetric laser endomicroscopy in imaging a rectal polyp,” Ther. Adv. Gastroenterol. 9(1), 128–131 (2016). http://dx.doi.org/10.1177/1756283X15615309 Google Scholar

87. D. C. Adler et al., “Three-dimensional endomicroscopy of the human colon using optical coherence tomography,” Opt. Express 17(2), 784–796 (2009).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.17.000784 Google Scholar

88. K. Liang et al., “Endoscopic forward-viewing optical coherence tomography and angiography with MHz swept source,” Opt. Lett. 42(16), 3193–3196 (2017).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.42.003193 Google Scholar

89. V. Pugliese et al., “Pancreatic intraductal sampling during ERCP in patients with chronic pancreatitis and pancreatic cancer: cytologic studies and K-RAS-2 codon 12 molecular analysis in 47 cases,” Gastrointest. Endoscopy 54(5), 595–599 (2001). http://dx.doi.org/10.1067/mge.2001.119220 Google Scholar

90. T. Rosch et al., “ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study,” Gastrointest. Endoscopy 60(3), 390–396 (2004). http://dx.doi.org/10.1016/S0016-5107(04)01732-8 Google Scholar

91. S. M. Selvaggi, “Biliary brushing cytology,” Cytopathology 15(2), 74–79 (2004).CYTPEU1365-2303 http://dx.doi.org/10.1111/cyt.2004.15.issue-2 Google Scholar

92. M. de Bellis et al., “Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2),” Gastrointest. Endoscopy 56(5), 720–730 (2002). http://dx.doi.org/10.1016/S0016-5107(02)70123-5 Google Scholar

93. U. Seitz et al., “First in vivo optical coherence tomography in the human bile duct,” Endoscopy 33(12), 1018–1021 (2001).ENDCAM http://dx.doi.org/10.1055/s-2001-18934 Google Scholar

94. J. M. Poneros et al., “Optical coherence tomography of the biliary tree during ERCP,” Gastrointest. Endoscopy 55(1), 84–88 (2002). http://dx.doi.org/10.1067/mge.2002.120098 Google Scholar

95. P. A. Testoni et al., “Intraductal optical coherence tomography for investigating main pancreatic duct strictures,” Am. J. Gastroenterol. 102(2), 269–274 (2007). http://dx.doi.org/10.1111/ajg.2007.102.issue-2 Google Scholar

96. A. Tyberg et al., “Second generation optical coherence tomography: preliminary experience in pancreatic and biliary strictures,” Gastroenterology 152(5), S1032–S1033 (2017).GASTAB0016-5085 http://dx.doi.org/10.1016/S0016-5085(17)33491-1 Google Scholar

97. V. Joshi et al., “A pilot study of safety and efficacy of directed cannulation with a low profile catheter (LP) and imaging characteristics of bile duct wall using optical coherance tomography (OCT) for Indeterminate biliary strictures initial report on in-vivo evaluation during ERCP,” Gastrointest. Endoscopy 85(5), AB496–AB497 (2017). http://dx.doi.org/10.1016/j.gie.2017.03.1150 Google Scholar

98. M.-M. Xu, S. M. Lagana and A. Sethi, “Use of optical coherence tomography (OCT) in the evaluation of gastric lesions,” Gastrointest. Endoscopy 81(5), AB462–AB463 (2015). http://dx.doi.org/10.1016/j.gie.2015.03.1667 Google Scholar

99. T.-H. Tsai et al., “Ultrahigh speed endoscopic optical coherence tomography for gastroenterology,” Biomed. Opt. Express 5(12), 4387–4404 (2014).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.5.004387 Google Scholar

100. H.-C. Lee et al., “Novel ultrahigh speed endoscopic OCT angiography identifies both architectural and microvascular changes in patients with Gastric Antral Vascular Ectasia (GAVE) undergoing Radiofrequency Ablation (RFA) treatment,” Gastroenterology 150(4), S435–S436 (2016).GASTAB0016-5085 http://dx.doi.org/10.1016/S0016-5085(16)31511-6 Google Scholar

101. E. Masci et al., “Pilot study on the correlation of optical coherence tomography with histology in celiac disease and normal subjects,” J. Gastroenterol. Hepatol. 22(12), 2256–2260 (2007).JGHEEO1440-1746 http://dx.doi.org/10.1111/jgh.2007.22.issue-12 Google Scholar

102. E. Masci et al., “Optical coherence tomography in pediatric patients: a feasible technique for diagnosing celiac disease in children with villous atrophy,” Digest. Liver Dis. 41(9), 639–643 (2009). http://dx.doi.org/10.1016/j.dld.2009.02.002 Google Scholar

103. A. K. Kamboj et al., “Use of volumetric laser endomicroscopy to characterize a duodenal neuroendocrine tumor,” Gastrointest. Endoscopy (In Press). Google Scholar

104. H.-C. Lee et al., “Endoscopic optical coherence tomography microangiography identifies the altered microvasculature of the terminal ileum in Crohn’s disease,” Gastrointest. Endoscopy 85(5), AB511–AB512 (2017). http://dx.doi.org/10.1016/j.gie.2017.03.1180 Google Scholar

105. R. Singh et al., “Narrow-band imaging with magnification in Barrett’s esophagus: validation of a simplified grading system of mucosal morphology patterns against histology,” Endoscopy 40(6), 457–463 (2008).ENDCAM http://dx.doi.org/10.1055/s-2007-995741 Google Scholar

106. J. A. Izatt et al., “In vivo bidirectional color Doppler flow imaging of picoliter blood volumes using optical coherence tomography,” Opt. Lett. 22(18), 1439–1441 (1997).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.22.001439 Google Scholar

107. V. X. Yang et al., “Endoscopic Doppler optical coherence tomography in the human GI tract: initial experience,” Gastrointest. Endoscopy 61(7), 879–890 (2005). http://dx.doi.org/10.1016/S0016-5107(05)00323-8 Google Scholar

108. S. Makita et al., “Optical coherence angiography,” Opt. Express 14(17), 7821–7840 (2006).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.14.007821 Google Scholar

109. R. K. Wang et al., “Three dimensional optical angiography,” Opt. Express 15(7), 4083–4097 (2007).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.15.004083 Google Scholar

110. H. W. Ren et al., “Real-time in vivo dblood-flow imaging by movingscatterer-sensitive spectral-domain optical Doppler tomography,” Opt. Lett. 31(7), 927–929 (2006).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.31.000927 Google Scholar

111. A. Mariampillai et al., “Speckle variance detection of microvasculature using swept-source optical coherence tomography,” Opt. Lett. 33(13), 1530–1532 (2008).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.33.001530 Google Scholar

112. Y. Jia et al., “Split-spectrum amplitude-decorrelation angiography with optical coherence tomography,” Opt. Express 20(4), 4710–4725 (2012).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.20.004710 Google Scholar

113. T.-H. Tsai et al., “Endoscopic optical coherence angiography enables three dimensional visualization of subsurface microvasculature,” Gastroenterology 147(6), 1219–1221 (2014).GASTAB0016-5085 http://dx.doi.org/10.1053/j.gastro.2014.08.034 Google Scholar

114. H. C. Lee et al., “Endoscopic optical coherence tomography angiography microvascular features associated with dysplasia in Barrett’s esophagus (with video),” Gastrointest. Endoscopy 86(3), 476–484 (2017). http://dx.doi.org/10.1016/j.gie.2017.01.034 Google Scholar

115. J. M. Schmitt, “OCT elastography: imaging microscopic deformation and strain of tissue,” Opt. Express 3(6), 199–211 (1998).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.3.000199 Google Scholar

116. J. Rogowska et al., “Optical coherence tomographic elastography technique for measuring deformation and strain of atherosclerotic tissues,” Heart (British Cardiac Society) 90(5), 556–562 (2004). http://dx.doi.org/10.1136/hrt.2003.016956 Google Scholar

117. B. F. Kennedy et al., “In vivo three-dimensional optical coherence elastography,” Opt. Express 19(7), 6623–6634 (2011).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.19.006623 Google Scholar

118. X. Liang and S. A. Boppart, “Biomechanical properties of in vivo human skin from dynamic optical coherence elastography,” IEEE Trans. Bio-med. Eng. 57(4), 953–959 (2010). http://dx.doi.org/10.1109/TBME.2009.2033464 Google Scholar

119. D. Alonso-Caneiro et al., “Assessment of corneal dynamics with high-speed swept source optical coherence tomography combined with an air puff system,” Opt. Express 19(15), 14188–14199 (2011).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.19.014188 Google Scholar

120. D. Chavan et al., “Collecting optical coherence elastography depth profiles with a micromachined cantilever probe,” Opt. Lett. 38(9), 1476–1478 (2013).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.38.001476 Google Scholar

121. K. M. Kennedy et al., “Quantitative micro-elastography: imaging of tissue elasticity using compression optical coherence elastography,” Sci. Rep. 5, 15538 (2015).SRCEC32045-2322 http://dx.doi.org/10.1038/srep15538 Google Scholar

122. W. M. Allen et al., “Wide-field optical coherence micro-elastography for intraoperative assessment of human breast cancer margins,” Biomed. Opt. Express 7(10), 4139–4153 (2016).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.7.004139 Google Scholar

123. K. M. Kennedy et al., “Needle optical coherence elastography for tissue boundary detection,” Opt. Lett. 37(12), 2310–2312 (2012).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.37.002310 Google Scholar

124. Y. Qiu et al., “Quantitative optical coherence elastography based on fiber-optic probe for in situ measurement of tissue mechanical properties,” Biomed. Opt. Express 7(2), 688–700 (2016).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.7.000688 Google Scholar

125. M. R. Hee et al., “Polarization-sensitive low-coherence reflectometer for birefringence characterization and ranging,” J. Opt. Soc. Am. B 9(6), 903–908 (1992).JOBPDE0740-3224 http://dx.doi.org/10.1364/JOSAB.9.000903 Google Scholar

126. J. F. De Boer et al., “Two-dimensional birefringence imaging in biological tissue by polarization-sensitive optical coherence tomography,” Opt. Lett. 22(12), 934–936 (1997).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.22.000934 Google Scholar

127. J. F. de Boer et al., “Imaging thermally damaged tissue by polarization sensitive optical coherence tomography,” Opt. Express 3(212), 212–218 (1998).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.3.000212 Google Scholar

128. C. E. Saxer et al., “High-speed fiber-based polarization-sensitive optical coherence tomography of in vivo human skin,” Opt. Lett. 25(18), 1355–1357 (2000).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.25.001355 Google Scholar

129. B. Cense et al., “In vivo depth-resolved birefringence measurements of the human retinal nerve fiber layer by polarization-sensitive optical coherence tomography,” Opt. Lett. 27(18), 1610–1612 (2002).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.27.001610 Google Scholar

130. W. C. Y. Lo et al., “Longitudinal, 3D imaging of collagen remodeling in murine hypertrophic scars in vivo using polarization-sensitive optical frequency domain imaging,” J. Invest. Dermatol. 136(1), 84–92 (2016).JIDEAE0022-202X http://dx.doi.org/10.1038/JID.2015.399 Google Scholar

131. W. Y. Oh et al., “High-speed polarization sensitive optical frequency domain imaging with frequency multiplexing,” Opt. Express 16(2), 1096–1103 (2008).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.16.001096 Google Scholar

132. M. Villiger et al., “Spectral binning for mitigation of polarization mode dispersion artifacts in catheter-based optical frequency domain imaging,” Opt. Express 21(14), 16353–16369 (2013).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.21.016353 Google Scholar

133. Z. Wang et al., “Depth-encoded all-fiber swept source polarization sensitive OCT,” Biomed. Opt. Express 5(9), 2931–2949 (2014).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.5.002931 Google Scholar

134. J. N. van der Sijde et al., “First-in-man assessment of plaque rupture by polarization-sensitive optical frequency domain imaging in vivo,” Eur. Heart J. 37(24), 1932–1932 (2016).EHJODF0195-668X http://dx.doi.org/10.1093/eurheartj/ehw179 Google Scholar

135. D. C. Adams et al., “Birefringence microscopy platform for assessing airway smooth muscle structure and function in vivo,” Sci. Transl. Med. 8(359), 359ra131 (2016).STMCBQ1946-6234 http://dx.doi.org/10.1126/scitranslmed.aag1424 Google Scholar

136. S. R. Puli et al., “Staging accuracy of esophageal cancer by endoscopic ultrasound: A meta-analysis and systematic review,” World J. Gastroenterol. 14(10), 1479–1490 (2008). http://dx.doi.org/10.3748/wjg.14.1479 Google Scholar

137. J. Yin et al., “Novel combined miniature optical coherence tomography ultrasound probe for in vivo intravascular imaging,” J. Biomed. Opt. 16(6), 060505 (2011).JBOPFO1083-3668 http://dx.doi.org/10.1117/1.3589097 Google Scholar

138. Y. Li et al., “Fully integrated optical coherence tomography, ultrasound, and indocyanine green-based fluorescence tri-modality system for intravascular imaging,” Biomed. Opt. Express 8(2), 1036–1044 (2017).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.8.001036 Google Scholar

139. L. Li et al., “Three-dimensional combined photoacoustic and optical coherence microscopy for in vivo microcirculation studies,” Opt. Express 17(19), 16450–16455 (2009).OPEXFF1094-4087 http://dx.doi.org/10.1364/OE.17.016450 Google Scholar

140. B. Zabihian et al., “In vivo dual-modality photoacoustic and optical coherence tomography imaging of human dermatological pathologies,” Biomed. Opt. Express 6(9), 3163–3178 (2015).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.6.003163 Google Scholar

141. L. Xi et al., “Miniature probe combining optical-resolution photoacoustic microscopy and optical coherence tomography for in vivo microcirculation study,” Appl. Opt. 52(9), 1928–1931 (2013).APOPAI0003-6935 http://dx.doi.org/10.1364/AO.52.001928 Google Scholar

142. X. Dai et al., “Miniature endoscope for multimodal imaging,” ACS Photonics 4(1), 174–180 (2017). http://dx.doi.org/10.1021/acsphotonics.6b00852 Google Scholar

143. H. F. Zhang et al., “Imaging of hemoglobin oxygen saturation variations in single vessels in vivo using photoacoustic microscopy,” Appl. Phys. Lett. 90(5), 053901 (2007).APPLAB0003-6951 http://dx.doi.org/10.1063/1.2435697 Google Scholar

144. L. V. Wang, “Prospects of photoacoustic tomography,” Med. Phys. 35(12), 5758–5767 (2008).MPHYA60094-2405 http://dx.doi.org/10.1118/1.3013698 Google Scholar

145. D. Lorenser et al., “Dual-modality needle probe for combined fluorescence imaging and three-dimensional optical coherence tomography,” Opt. Lett. 38(3), 266–268 (2013).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.38.000266 Google Scholar

146. H. Pahlevaninezhad et al., “Endoscopic Doppler optical coherence tomography and autofluorescence imaging of peripheral pulmonary nodules and vasculature,” Biomed. Opt. Express 6(10), 4191–4199 (2015).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.6.004191 Google Scholar

147. S. Liang et al., “Intravascular atherosclerotic imaging with combined fluorescence and optical coherence tomography probe based on a double-clad fiber combiner,” J. Biomed. Opt. 17(7), 070501 (2012).JBOPFO1083-3668 http://dx.doi.org/10.1117/1.JBO.17.7.070501 Google Scholar

148. H. Yoo et al., “Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo,” Nat. Med. 17(12), 1680–1684 (2011).1078-8956 http://dx.doi.org/10.1038/nm.2555 Google Scholar

149. G. J. Ughi et al., “Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging,” Int. J. Cardiovasc. Imaging 31(2), 259–268 (2015). http://dx.doi.org/10.1007/s10554-014-0556-z Google Scholar

150. J. Mavadia et al., “An all-fiber-optic endoscopy platform for simultaneous OCT and fluorescence imaging,” Biomed. Opt. Express 3(11), 2851–2859 (2012).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.3.002851 Google Scholar

151. J. Xi et al., “Integrated multimodal endomicroscopy platform for simultaneous en face optical coherence and two-photon fluorescence imaging,” Opt. Lett. 37(3), 362–364 (2012).OPLEDP0146-9592 http://dx.doi.org/10.1364/OL.37.000362 Google Scholar

152. K. M. Tan et al., “Flexible transbronchial optical frequency domain imaging smart needle for biopsy guidance,” Biomed. Opt. Express 3(8), 1947–1954 (2012).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.3.001947 Google Scholar

153. W.-C. Kuo et al., “Real-time three-dimensional optical coherence tomography image-guided core-needle biopsy system,” Biomed. Opt. Express 3(6), 1149–1161 (2012).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.3.001149 Google Scholar

154. R. A. McLaughlin et al., “Static and dynamic imaging of alveoli using optical coherence tomography needle probes,” J. Appl. Physiol. 113(6), 967–974 (2012). http://dx.doi.org/10.1152/japplphysiol.00051.2012 Google Scholar

155. K. Beaudette et al., “Laser tissue coagulation and concurrent optical coherence tomography through a double-clad fiber coupler,” Biomed. Opt. Express 6(4), 1293–1303 (2015).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.6.001293 Google Scholar

156. J. Sauk et al., “Interobserver agreement for the detection of Barrett’s esophagus with optical frequency domain imaging,” Dig. Dis. Sci. 58(8), 2261–2265 (2013).DDSCDJ0163-2116 http://dx.doi.org/10.1007/s10620-013-2625-x Google Scholar

157. A. J. Trindade et al., “Volumetric laser endomicroscopy in Barrett’s esophagus: interobserver agreement for interpretation of Barrett’s esophagus and associated neoplasia among high-frequency users,” Gastrointest. Endoscopy 86(1), 133–139 (2017). http://dx.doi.org/10.1016/j.gie.2016.11.026 Google Scholar

158. G. J. Ughi et al., “Automated segmentation and characterization of esophageal wall in vivo by tethered capsule optical coherence tomography endomicroscopy,” Biomed. Opt. Express 7(2), 409–419 (2016).BOEICL2156-7085 http://dx.doi.org/10.1364/BOE.7.000409 Google Scholar

159. A. K. Kamboj et al., “Detection of Barrett’s esophagus dysplasia using a novel volumetric laser endomicroscopy computer algorithm,” Gastrointest. Endoscopy 85(5), AB518 (2017). http://dx.doi.org/10.1016/j.gie.2017.03.1193 Google Scholar

160. E. Rodriguez-Diaz and S. K. Singh, “Computer-assisted analysis of hypo-scattering glandular structures in Barrett’s dysplasia observed by volumetric laser endomicroscopy,” Gastroenterology 152(5), S840 (2017).GASTAB0016-5085 http://dx.doi.org/10.1016/S0016-5085(17)32900-1 Google Scholar

161. A. F. Swager et al., “Quantitative attenuation analysis for identification of early Barrett’s neoplasia in volumetric laser endomicroscopy,” J. Biomed. Opt. 22(8), 086001 (2017).JBOPFO1083-3668 http://dx.doi.org/10.1117/1.JBO.22.8.086001 Google Scholar

162. A.-F. Swager et al., “Computer-aided detection of early Barrett’s neoplasia using volumetric laser endomicroscopy,” Gastrointest. Endoscopy 86(5), 839–846 (2017). http://dx.doi.org/10.1016/j.gie.2017.03.011 Google Scholar

Biographies for the authors are not available.

© 2017 Society of Photo-Optical Instrumentation Engineers (SPIE)
Tsung-Han Tsai, Cadman L. Leggett, Arvind J. Trindade, Amrita Sethi, Anne-Fré Swager, Virendra Joshi, Jacques J. Bergman, Hiroshi Mashimo, Norman S. Nishioka, Eman Namati, "Optical coherence tomography in gastroenterology: a review and future outlook," Journal of Biomedical Optics 22(12), 121716 (19 December 2017). https://doi.org/10.1117/1.JBO.22.12.121716 Submission: Received 7 September 2017; Accepted 5 December 2017
Submission: Received 7 September 2017; Accepted 5 December 2017
JOURNAL ARTICLE
17 PAGES


SHARE
Back to Top